Professor of Medicine, Medical College VA
Cardiology
Dr. George W. Vetrovec, MD
|
|
Give Review
George Vetrovec works in the field of Cardiology. He researched medicine at University of Virginia School of Medicine. He over the years received 3 awards: "America's Top Doctors", "Top MD" and "Whos Who in Medicine and Healthcare". George Vetrovec is also a published doctor. He has 64 publication published. The most recent publication is: Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. George Vetrovec is registered with Medicare.
Publications
- Percutaneous left ventricular assist device for high-risk percutaneous Coronary interventions: Real-world versus clinical trial experience.
- DES: Timing May Be Everything.
- The association between experience and proficiency with robotic-enhanced Coronary intervention-insights from the PRECISE multi-center study.
- Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Cardiac Arrest (from the NCDR).
- Lower Hospital Volume Is Associated With Higher In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocar...
- Safety and Feasibility of Robotic Percutaneous Coronary Intervention - The Multi-Center Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE).
- Conversation in cardiology: Should FFR and IVUS be counted as pci?
- Kidneys Outwit DES: Round One.
- Sympathectomy as a treatment for refractory Coronary artery spasm.
- Left Circumflex Occlusion in Acute Myocardial Infarction (from the National Cardiovascular Data Registry).
- The Editor's Roundtable: Contrast Agents and Risk for Contrast-Induced Nephropathy.
- Outcomes in patients with chronicity of left bundle-branch block with possible Acute myocardial infarction.
- Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.
- Drug eluting stents in CTOs: why not?
- Clinical outcomes in patients with Acute left circumflex/obtuse marginal occlusion presenting with myocardial infarction.
- Relation between the incidence, location, and extent of thoracic aortic atherosclerosis detected by transesophageal echocardiography and the extent of Coronary artery ...
- Thrombus aspiration for restoring flow: stents for scaffolding?
- Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures.
- Emergency physician-initiated cath lab activation reduces door to balloon times in ST-segment elevation Myocardial infarction patients.
- Its all about time and talent.
- Evidence based management of patients undergoing PCI. Conclusion.
- Evidence-based management of patients undergoing PCI: stent controversies.
- Meta-analysis of randomized controlled trials of statins versus placebo in patients with Heart failure.
- Hemoglobin levels predict exercise performance, ST-segment depression, and outcome in patients referred for routine exercise treadmill testing.
- Apoptosis in patients with Acute myocarditis.
- SES for AMI: moving in the right direction.
- Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.
- Anakinra in experimental Acute myocardial infarction--does dosage or duration of treatment matter?
- Left anterior descending Coronary artery revascularization patient-tailored therapy?
- Right ventricular cardiomyocyte apoptosis in patients with Acute myocardial infarction of the left ventricular wall.
- Safety of drug-eluting stents in patients with left ventricular dysfunction undergoing percutaneous Coronary intervention.
- Recognizing and reducing the cardiac risk of renal Failure.
- The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
- Relation of blood urea nitrogen to long-term mortality in patients with Heart failure.
- Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental Acute myocardial infarction.
- Late open Artery hypothesis in clinical practice-is it a "dead" issue?
- Drug eluting stents in AMI: keep the data coming.
- Survival and cardiac remodeling benefits in patients undergoing late percutaneous Coronary intervention of the infarct-related artery: evidence from a meta-analysis of...
- Role of apoptosis in pressure-overload Cardiomyopathy.
- Improving reperfusion in patients with Myocardial infarction.
- Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous Coronary intervention.
- The editor's roundtable: chronic stable Angina pectoris.
- Moving in the right direction.
- Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postInfarction remodeling in the rat.
- Impact of intracoronary cell therapy on left ventricular function in the setting of Acute myocardial infarction: a collaborative systematic review and meta-analysis of...
- ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures a report of the American College of Cardiology Foundation/American ...
- Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic Heart failure.
- Left ventricular diastolic filling pattern at Doppler echocardiography and apoptotic rate in fatal Acute myocardial infarction.
- Gender comparison of efficacy and safety of ranolazine for chronic Angina pectoris in four randomized clinical trials.
- Magnetic guidance for percutaneous Coronary intervention: is it attractive?
- Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo Coronary lesions.
- Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous Coronary intervention.
- Improved survival for stenting vs. balloon angioplasty for the treatment of Coronary artery disease in patients with ischemic left ventricular dysfunction.
- The importance of Heart rate recovery in patients with Heart failure or left ventricular systolic dysfunction.
- Optimizing percutaneous Coronary intervention outcomes: the next steps.
- The current and future role of percutaneous Coronary intervention in patients with Coronary artery disease.
- Working group 8: Defining the different types of cardiovascular specialists and developing a new model for training general clinical cardiologists.
- Don't blame the stents.
- Feasibility of endovascular cooling as an adjunct to primary percutaneous Coronary intervention (results of the LOWTEMP pilot study).
- Importance of the first two minutes of Heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men.
- Designer stents and restenosis.
- The price for perhaps four hours of earlier ambulation.
- Drug-eluting stents: current outcomes and potential impact on Coronary disease management.
Schools
Virginia Commonwealth University School Of Medicine
Med College Va
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Top MD
- Whos Who in Medicine and Healthcare
Education
-
Virginia Commonwealth University Health System -
University of Virginia School of Medicine
Hospital
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1801986450 | |
| NPPES Provider LastName | VETROVEC | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 633.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801986450 |
| Last Name Of The Provider | VETROVEC |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
|
Dr. Deepa Nandyal, MD |
|
|
Dr. Hamid M. Al-Abdulla, MD |
|
|
Dr. Jordana Kron, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bethany L. Denlinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Peberdy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael J. Cowley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter S. Ro, MD |
|
|
Dr. David A. Cotoni, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andreas W. Prinz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Minisi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John E. Fitzgerald, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minh N. Bui, MD |
|
Dr. Gansevoort H. Dunnington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan D. Melchior, DO |